Vai al contenuto principale della pagina
| Titolo: |
Guidance for industry [[electronic resource] ] : postmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic
|
| Pubblicazione: | Rockville, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats : , : Center for Drug Evaluation and Research : , : Center for Biologics Evaluation and Research : , : Center for Devices and Radiological Health : , : Center for Food Safety and Applied Nutrition, , [2008] |
| Descrizione fisica: | 1 online resource (12 pages) |
| Soggetto topico: | Drugs - Side effects - Reporting - Government policy - United States |
| Dietary supplements - Government policy - United States | |
| Influenza | |
| Note generali: | "Draft guidance". |
| "Procedural". | |
| "December 2008". | |
| Altri titoli varianti: | Guidance for industry |
| Titolo autorizzato: | Guidance for industry ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910698954603321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |